Table 1.
Statewise prevalence of SMA in Australia.
| State/territory | Number (n) of individuals enrolled in ANMDR | Minimum prevalencea |
|---|---|---|
| Victoria (VIC) Jurisdictionally includes Tasmania (TAS) |
80 | 1.19/100,000 |
| New South Wales (NSW) and Australian Capital Territory (ACT) Jurisdictionally include Northern Territory (NT) |
55 | 0.63/100,000 |
| Queensland (QLD) | 28 | 0.52/100,000 |
| Western Australia (WA) | 19 | 0.67/100,000 |
| South Australia (SA) | 8 | 0.49/100,0000 |
| Australia wide | 190 | 0.73/100,000b |
a
95% CI 0.63–0.84/100,000.
b
Australian Bureau of Statistics (March 2023), National, state and territory population.